Our results indicate that CHI3L1 could up-regulate the expression of Mcl-1 in favor of anti-apoptotic pathways to hamper the apoptosis induced by chemotherapeutic drugs in ovarian cancer cells. This evidence concerns the gene CHI3L1 and ovarian carcinoma.